Cargando…
Author Correction: Empagliflozin improves post-infarction cardiac remodeling through GTP enzyme cyclohydrolase 1 and irrespective of diabetes status
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547718/ https://www.ncbi.nlm.nih.gov/pubmed/33037250 http://dx.doi.org/10.1038/s41598-020-73065-5 |
| _version_ | 1783592478233853952 |
|---|---|
| author | del Carmen Asensio Lopez, Maria Lax, Antonio Hernandez Vicente, Alvaro Saura Guillen, Elena Hernandez-Martinez, Antonio Fernandez del Palacio, Maria Josefa Bayes-Genis, Antoni Pascual Figal, Domingo A. |
| author_facet | del Carmen Asensio Lopez, Maria Lax, Antonio Hernandez Vicente, Alvaro Saura Guillen, Elena Hernandez-Martinez, Antonio Fernandez del Palacio, Maria Josefa Bayes-Genis, Antoni Pascual Figal, Domingo A. |
| author_sort | del Carmen Asensio Lopez, Maria |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7547718 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-75477182020-10-14 Author Correction: Empagliflozin improves post-infarction cardiac remodeling through GTP enzyme cyclohydrolase 1 and irrespective of diabetes status del Carmen Asensio Lopez, Maria Lax, Antonio Hernandez Vicente, Alvaro Saura Guillen, Elena Hernandez-Martinez, Antonio Fernandez del Palacio, Maria Josefa Bayes-Genis, Antoni Pascual Figal, Domingo A. Sci Rep Author Correction Nature Publishing Group UK 2020-10-09 /pmc/articles/PMC7547718/ /pubmed/33037250 http://dx.doi.org/10.1038/s41598-020-73065-5 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Author Correction del Carmen Asensio Lopez, Maria Lax, Antonio Hernandez Vicente, Alvaro Saura Guillen, Elena Hernandez-Martinez, Antonio Fernandez del Palacio, Maria Josefa Bayes-Genis, Antoni Pascual Figal, Domingo A. Author Correction: Empagliflozin improves post-infarction cardiac remodeling through GTP enzyme cyclohydrolase 1 and irrespective of diabetes status |
| title | Author Correction: Empagliflozin improves post-infarction cardiac remodeling through GTP enzyme cyclohydrolase 1 and irrespective of diabetes status |
| title_full | Author Correction: Empagliflozin improves post-infarction cardiac remodeling through GTP enzyme cyclohydrolase 1 and irrespective of diabetes status |
| title_fullStr | Author Correction: Empagliflozin improves post-infarction cardiac remodeling through GTP enzyme cyclohydrolase 1 and irrespective of diabetes status |
| title_full_unstemmed | Author Correction: Empagliflozin improves post-infarction cardiac remodeling through GTP enzyme cyclohydrolase 1 and irrespective of diabetes status |
| title_short | Author Correction: Empagliflozin improves post-infarction cardiac remodeling through GTP enzyme cyclohydrolase 1 and irrespective of diabetes status |
| title_sort | author correction: empagliflozin improves post-infarction cardiac remodeling through gtp enzyme cyclohydrolase 1 and irrespective of diabetes status |
| topic | Author Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547718/ https://www.ncbi.nlm.nih.gov/pubmed/33037250 http://dx.doi.org/10.1038/s41598-020-73065-5 |
| work_keys_str_mv | AT delcarmenasensiolopezmaria authorcorrectionempagliflozinimprovespostinfarctioncardiacremodelingthroughgtpenzymecyclohydrolase1andirrespectiveofdiabetesstatus AT laxantonio authorcorrectionempagliflozinimprovespostinfarctioncardiacremodelingthroughgtpenzymecyclohydrolase1andirrespectiveofdiabetesstatus AT hernandezvicentealvaro authorcorrectionempagliflozinimprovespostinfarctioncardiacremodelingthroughgtpenzymecyclohydrolase1andirrespectiveofdiabetesstatus AT sauraguillenelena authorcorrectionempagliflozinimprovespostinfarctioncardiacremodelingthroughgtpenzymecyclohydrolase1andirrespectiveofdiabetesstatus AT hernandezmartinezantonio authorcorrectionempagliflozinimprovespostinfarctioncardiacremodelingthroughgtpenzymecyclohydrolase1andirrespectiveofdiabetesstatus AT fernandezdelpalaciomariajosefa authorcorrectionempagliflozinimprovespostinfarctioncardiacremodelingthroughgtpenzymecyclohydrolase1andirrespectiveofdiabetesstatus AT bayesgenisantoni authorcorrectionempagliflozinimprovespostinfarctioncardiacremodelingthroughgtpenzymecyclohydrolase1andirrespectiveofdiabetesstatus AT pascualfigaldomingoa authorcorrectionempagliflozinimprovespostinfarctioncardiacremodelingthroughgtpenzymecyclohydrolase1andirrespectiveofdiabetesstatus |